Market Value Added (MVA)
Market value added (MVA) is the difference between a firm fair value and its invested capital. MVA is a measure of the value a company has created in excess of the resources already committed to the enterprise.
MVA
Boston Scientific Corp., MVA calculation
US$ in millions
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 Fair value of debt. See details »
2 Invested capital. See details »
| Item | Description | The company |
|---|---|---|
| MVA | Boston Scientific Corp. market (fair) value less invested capital. | Boston Scientific Corp. MVA increased from 2020 to 2021 and from 2021 to 2022. |
MVA Spread Ratio
Boston Scientific Corp., MVA spread ratio calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Market value added (MVA)1 | 53,436) | 50,980) | 45,107) | 46,696) | 46,744) | |
| Invested capital2 | 22,868) | 22,038) | 21,053) | 20,389) | 16,047) | |
| Performance Ratio | ||||||
| MVA spread ratio3 | 233.67% | 231.33% | 214.26% | 229.03% | 291.30% | |
| Benchmarks | ||||||
| MVA Spread Ratio, Competitors4 | ||||||
| Abbott Laboratories | 230.60% | 266.78% | 300.18% | 202.12% | — | |
| Cigna Group | 36.39% | 21.75% | 20.67% | 16.09% | — | |
| CVS Health Corp. | 26.73% | 49.51% | 20.97% | 20.89% | — | |
| Elevance Health Inc. | 108.24% | 115.84% | 72.12% | 79.88% | — | |
| Humana Inc. | 156.66% | 122.92% | 163.20% | 196.12% | — | |
| Intuitive Surgical Inc. | 1,400.02% | 2,002.36% | 1,853.43% | 1,771.30% | — | |
| Medtronic PLC | 93.80% | 163.10% | 107.64% | 113.36% | 91.81% | |
| Shockwave Medical Inc. | 2,047.13% | 3,455.61% | 4,218.08% | 459.40% | — | |
| UnitedHealth Group Inc. | 214.27% | 265.59% | 189.93% | 187.47% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 MVA. See details »
2 Invested capital. See details »
3 2022 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × 53,436 ÷ 22,868 = 233.67%
4 Click competitor name to see calculations.
| Performance ratio | Description | The company |
|---|---|---|
| MVA spread ratio | The ratio of MVA to invested capital. It measures the efficiency with which investors’ capital investment has translated into a franchise value and into an aggregate net present value premium. | Boston Scientific Corp. MVA spread ratio improved from 2020 to 2021 and from 2021 to 2022. |
MVA Margin
Boston Scientific Corp., MVA margin calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Market value added (MVA)1 | 53,436) | 50,980) | 45,107) | 46,696) | 46,744) | |
| Net sales | 12,682) | 11,888) | 9,913) | 10,735) | 9,823) | |
| Add: Increase (decrease) in deferred revenue | 25) | 89) | (5) | 27) | —) | |
| Adjusted net sales | 12,707) | 11,977) | 9,908) | 10,762) | 9,823) | |
| Performance Ratio | ||||||
| MVA margin2 | 420.52% | 425.65% | 455.26% | 433.90% | 475.87% | |
| Benchmarks | ||||||
| MVA Margin, Competitors3 | ||||||
| Abbott Laboratories | 323.76% | 384.46% | 523.78% | 368.47% | — | |
| Cigna Group | 17.38% | 11.43% | 12.17% | 9.91% | — | |
| CVS Health Corp. | 10.28% | 22.27% | 10.70% | 11.44% | — | |
| Elevance Health Inc. | 46.51% | 54.14% | 33.92% | 42.99% | — | |
| Humana Inc. | 49.25% | 45.49% | 46.87% | 57.53% | — | |
| Intuitive Surgical Inc. | 1,209.45% | 1,575.51% | 1,900.32% | 1,312.48% | — | |
| Medtronic PLC | 205.92% | 391.27% | 264.99% | 269.43% | 217.26% | |
| Shockwave Medical Inc. | 1,329.51% | 2,539.18% | 5,679.41% | 1,698.10% | — | |
| UnitedHealth Group Inc. | 109.81% | 130.39% | 96.88% | 91.49% | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 MVA. See details »
2 2022 Calculation
MVA margin = 100 × MVA ÷ Adjusted net sales
= 100 × 53,436 ÷ 12,707 = 420.52%
3 Click competitor name to see calculations.
| Performance ratio | Description | The company |
|---|---|---|
| MVA margin | The ratio of MVA to sales. It measures how efficiently and prodigiously sales translate into franchise value. | Boston Scientific Corp. MVA margin ratio deteriorated from 2020 to 2021 and from 2021 to 2022. |